✦ LIBER ✦

414 Correlation of mutations in EGFR with clinical outcomes in NSCLC patients treated with erlotinib

✍ Scribed by D. Eberhard; L. Amler; A. Goddard; W. Ince; T. Januario; K. Hillan; M. Ostland; D. Ramies; S. Seshagiri; P. Klein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR CA repeat polymorphism predict clin

✍ Winther Larsen, Anne; Nissen, Peter Henrik; Meldgaard, Peter; Weber, Britta; Sor 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 695 KB

24 Outcome in metastatic NSCLC without E

✍ Dua, D.; Montes, A.; Warner, M.; Spicer, J.; Lal, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9154 Clinical outcomes in patients with

✍ Paz-Ares, L.; Soulières, D.; Klughammer, B.; Melezínek, I.; Moecks, J.; Keil, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

O-186 Mutations in EGFR, HER2, KRAS and

✍ Eberhard, D.; Johnson, B.; Goddard, A.; Herbst, R.; Janne, P.; Johnson, D.; Klei 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 185 KB

EGFR mutations in patients with non-smal

✍ S. Ricciardi; B. Tedesco; M.R. Migliorino; P. Graziano; A. Leone; M. Di Salvia; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Is there any predictor for clinical outc

✍ Lee, Ji Yun; Lim, Sung Hee; Kim, Moonjin; Kim, Sungmin; Jung, Hyun Ae; Chang, Wo 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 258 KB